Steffen Leth

Associate Professor

Aarhus University
Country flagDenmark

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Objectives: People with HIV (PWH) are unable to get private disability insurance on a regular basis in contrast with individuals with other chronic diseases. We aimed to estimate the risk of public disability pension and work absence due to sickness for PWH compared with the background population in Denmark. Design: Nationwide, population-based, matched cohort study of employed PWH with favorable disease characteristics. A comparison cohort of employed individuals was matched 10 : 1 to PWH by date of birth and sex from the general population. Methods: We computed time to first date of 4 weeks of uninterrupted sick leave, 26 weeks of uninterrupted sick leave, and disability pension being granted. We used Cox regression to obtain hazard ratios (HRs) as a measure of relative risk and competing risk analysis to assess absolute risk. Results: After 6 months of observation, PWH had an increased risk of 4-week sick leave, 26-week sick leave and disability pension compared with the comparison cohort (HR of 1.1 [95% CI: 1.0–1.2), 1.4 (95% CI: 1.1–1.6) and 2.0 (95% CI: 1.5–2.6), respectively]. These risks were increased in most patient subgroups. Conclusion: PWH have an increased risk of prolonged sick leave and disability pension, and a slightly increased risk of 4-week sick leave. These risks were within the range of what is described for other chronic diseases. PWH with contemporary cART and favorable disease characteristics should not be generally excluded from access to private disability insurance.

Year:

2026

Background: Mental health has become an area of concern among people with HIV (PWH). We aim to assess whether the risk of schizophrenia spectrum disorders (SSD) is increased among PWH. To examine whether such risks are affected by familial factors we also accessed the risk among their siblings. Methods: Nationwide, population-based, matched cohort study of PWH with Danish origin (1995–2021), a comparison cohort from the background population, matched on date of birth and gender, and sibling cohorts. We used cumulative incidence function and Cox regression to estimate absolute risk and hazard ratios (HR) with 95% confidence intervals (CI) of study outcomes and stratified the results according to route of HIV transmission. Findings: We observed an increased risk of SSD among PWH [20-year cumulative incidence 3.7% vs. 1.0% and HR 4.6 (95% CI: 3.8–5.6)], especially among individuals with injection drug use (IDU) as route of HIV transmission [HR 11.3 (95% CI: 7.7–16.4)]. Among siblings increased risk of SSD was mainly observed among siblings of PWH with IDU as route of HIV transmission [HR of 2.9 (95% CI: 1.9–4.5)] and with lack of statistical power among siblings of PWH with men who have sex with men and heterosexual contact as routes of HIV transmission [HR 1.3 (95% CI: 0.9–1.7) and HR 1.2 (95% CI: 0.7–1.9)]. Interpretation: Risk of SSD is substantially increased among PWH, especially among those who report IDU as route of HIV transmission. Familial risk factors might partly contribute to this risk.

Year:

2026

Year:

2026

Long COVID represents a significant global health challenge with an unclear etiology. Alongside accumulating evidence of mitochondrial dysfunction in patients with acute SARS‐CoV‐2 infection, a symptomatic overlap exists between long COVID and mitochondrial disorders. However, the genetic underpinnings of mitochondrial dysfunction in long COVID have not been previously explored. We employed whole genome sequencing to analyze 13 patients with severe long COVID to identify genetic defects related to mitochondrial function. We performed extracellular bioenergetics flux analysis on peripheral blood mononuclear cells and proteomics to evaluate cellular bioenergetics and compared the results to those of healthy controls. Our investigation identified 10 variants classified as pathogenic or likely pathogenic and 83 variants of unknown significance affecting a wide range of mitochondria‐associated biological functions. Bioenergetics flux analysis in peripheral blood mononuclear cells revealed an altered ATP production rate in four long COVID patients compared to healthy controls. This study presents initial evidence of a potential underlying genetic predisposition to mitochondrial dysfunction in long COVID while demonstrating altered cellular energy capacity in a subset of these patients. These findings open avenues for further research into the role of mitochondrial dysfunction and pathology in patients suffering from long COVID and may pave the way for targeted therapeutic strategies aimed at mitigating mitochondrial dysfunction.

Year:

2025

Year:

2025

Introduction The Post-COVID-19 Functional Status (PCFS) scale was quickly adopted into COVID-19 research and clinical practice worldwide to monitor functional status and recovery. The scale has been translated into Danish, and three different administration methods have been employed. However, clinicians have expressed concerns about the scale's ability to capture work-related functional limitations. Therefore, the purpose of this study was to evaluate the construct validity of three different administration methods of the Danish version of the PCFS scale. Methods This cross-sectional study included patients with long COVID who completed three versions of the PCFS scale: a questionnaire-based version, a flowchart-based version, and an interview-based version. The construct validity was evaluated following the Consensus-based Standards for the selection of health Measurement Instruments (COSMIN) guidelines by testing predefined hypotheses that compared the PCFS scale with sick leave and EuroQoL Five-dimensions Five level (EQ-5D-5l). Results A total of 437 patients, with a mean age 48 years, 75% female, and 59% on sick leave, were included in this study. Statistically significant differences between the three administration methods were found. Of the 234 patients on sick leave, only 50%-54% had a PCFS grade ≥3 which was below our predefined hypothesis. Furthermore, correlations between the PCFS scale and EQ-5D-5l was lower than hypothesized. Conclusion None of the three administration methods effectively captured work-related functional limitations associated with being on part-time or full-time sick leave. Additionally, correlations with quality of life were lower than expected. Overall, the construct validity of the PCFS scale was only partially supported.

Year:

2025

Myasthenic crisis is a severe complication of myasthenia gravis (MG) characterized by respiratory failure. This case report presents a 24-year-old woman admitted with respiratory distress, eventually diagnosed with myasthenic crisis triggered by COVID-19. Initial symptoms included throat pain and dysphagia with no evident pathology. Elevated acetylcholine receptor antibodies confirmed MG. The case underscores the importance of considering neuromuscular diseases in unexplained respiratory failure, highlighting early diagnosis and treatment as key to reducing the need for invasive ventilation.

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (33)

nilanjan dey

Aarhus University

DENMARK
View details

Søren Sperling

Aarhus University

DENMARK
View details

Sofie Eg Jørgensen

Assistant professor

Aarhus University

DENMARK
View details

Michael Dalager-Pedersen

Aalborg University

DENMARK
View details

Pelle Trier Petersen

Zealand University Hospital

DENMARK
View details

Martin Tolstrup

Professor

Aarhus University

DENMARK
View details

Kristoffer Skaalum Hansen

Aarhus University

DENMARK
View details

Anne-Mette Lebech

Københavns Universitet

DENMARK
View details

Jesper Falkesgaard Højen

Aarhus University

DENMARK
View details

Jens Bukh

Professor

Københavns Universitet

DENMARK
View details

Peer Brehm Christensen

University of Southern Denmark

DENMARK
View details

Johan Palmfeldt

VIP, Associate Professor

Aarhus University

DENMARK
View details

Ida Monrad Johannsen

Aarhus University

DENMARK
View details

Lotte Sørensen

DVIP-part-time lecturer, Part-time Lecturer

Aarhus University

DENMARK
View details

Morten Kelder Skouboe

Aarhus University

DENMARK
View details

Jesper Gunst

VIP, Associate Professor

Aarhus University

DENMARK
View details

Britta Tarp

Consultant, PhD, Associate professor, DTM&H

Aarhus University

DENMARK
View details

Jillian Lau

Peter Doherty Institute

AUSTRALIA
View details

Johannes Schmid

VIP, Clinical Associate Professor

Aarhus University

DENMARK
View details

Jane Agergaard

Aarhus University Hospital

DENMARK
View details

Andreas Fløe

VIP, Clinical Associate Professor

Aarhus University

DENMARK
View details

Lars H Omland

Copenhagen University Hospital

DENMARK
View details

Lisa Gregersen Oestergaard

VIP, Associate Professor

Aarhus University

DENMARK
View details

Isik Somuncu Johansen

University of Southern Denmark

DENMARK
View details

Paul Denton

Associate Professor

University of Nebraska Omaha

UNITED STATES
View details

Lars Østergaard

Professor

Aarhus University

DENMARK
View details

Thomas Aagaard Rasmussen

Aarhus University Hospital

DENMARK
View details

Charlotte Hyldgaard

VIP, Clinical Associate Professor

Aarhus University

DENMARK
View details

Dorthe Sørensen

DVIP-part-time lecturer, Part-time Lecturer

Aarhus University

DENMARK
View details

Trine Hyrup Mogensen

DVIP-external, Professor

Aarhus University

DENMARK
View details

Claus Vinther Nielsen

VIP, Professor

Aarhus University

DENMARK
View details

Merete Storgaard

VIP, Clinical Associate Professor

Aarhus University

DENMARK
View details

Berit Schiøttz Christensen

Professor

University of Southern Denmark

DENMARK
View details